The financial operations and treasury functions of Karyopharm Therapeutics are directed by Lori Macomber, who serves as the Executive Vice President, Chief Financial Officer, and Treasurer. Bringing extensive financial management experience across commercial-stage life science corporations and biopharmaceutical firms, she oversees the company's financial strategies, capital allocation, budget discipline, and reporting frameworks to support ongoing commercial growth and clinical pipeline advancement.